2,3-dihydro-iminoisoindole derivatives

Details 2,3-dihydro-iminoisoindole derivatives 2,3-dihydro-iminoisoindole derivatives

2008-09-19

2010-10-05

Shameem, Golam M. M. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S339000, C514S370000, C514S377000, C514S384000, C544S331000, C546S272400, C548S181000, C548S233000, C548S264200

Reexamination Certificate

active

07807690

ABSTRACT:
A compound represented by the following general formula (1), or a salt thereof has serine protease inhibiting activity, and particularly excellent inhibiting activity against clotting factor VIIa. This compound or a salt thereof is useful as therapeutic and/or prophylactic agents for diseases associated with thrombus formation.[wherein R1represents hydrogen, R2represents optionally substituted phenyl, etc., R3represents optionally substituted C6-10 aryl, etc.].

REFERENCES:
patent: 6916837 (2005-07-01), Satoh et al.
patent: 7576098 (2009-08-01), Glunz et al.
patent: 2002/0004608 (2002-01-01), Alig et al.
patent: 2002/0052417 (2002-05-01), Klingler et al.
patent: 2003/0181766 (2003-09-01), Satoh et al.
patent: 2004/0242627 (2004-12-01), Suzuki et al.
patent: 2004/0254376 (2004-12-01), Suzuki et al.
patent: 2005/0004197 (2005-01-01), Suzuki et al.
patent: 2005/0004204 (2005-01-01), Suzuki et al.
patent: 2005/0245592 (2005-11-01), Suzuki et al.
patent: 2008/0015199 (2008-01-01), Clark et al.
patent: 2008/0132507 (2008-06-01), Clark et al.
patent: 2009/0270433 (2009-10-01), Clark et al.
patent: 58281/80 (1980-11-01), None
patent: 0 019 586 (1980-11-01), None
patent: 1 020 434 (2000-07-01), None
patent: 1 078 917 (2001-02-01), None
patent: 1 312 602 (2003-05-01), None
patent: 2002-509924 (2002-04-01), None
patent: 2002-543176 (2002-12-01), None
patent: 2003-212837 (2003-07-01), None
patent: 2003-534311 (2003-11-01), None
patent: 2003-535844 (2003-12-01), None
patent: 1512055 (1992-07-01), None
patent: WO-99/10316 (1999-03-01), None
patent: WO-99/41231 (1999-08-01), None
patent: WO-99/50255 (1999-10-01), None
patent: WO-00/35858 (2000-06-01), None
patent: WO-00/41531 (2000-07-01), None
patent: WO-00/58346 (2000-10-01), None
patent: WO-00/66545 (2000-11-01), None
patent: WO-02/085855 (2002-10-01), None
patent: WO-2004/032846 (2004-04-01), None
patent: WO-2004/101555 (2004-11-01), None
patent: WO-2006/062972 (2006-06-01), None
patent: WO 2007/111212 (2007-10-01), None
patent: WO-2007/111212 (2007-10-01), None
“cancer.” MedLine Plus. (2009). Accessed Mar. 17, 2009. <http://www.nlm.nih.gov/medlineplus/cancer.html>.
Golub et al. “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring.” Science (1999), vol. 286, 521-537.
Lala et al. “Role of nitric oxide in tumor progression: Lessons from experimental tumors.” Cancer and Metastasis Reviews (1998), 17(1), 91-106.
Roussel, P. et al., “Inhibition of the Tissue Factor/Factor Vlla Complex—Lead Optimisation Using Combinatorial Chemistry”, Tetrahedron vol. 55, 1999, pp. 6219-6230.
Vippagunta et al., “Crystalline Solids,”Adv. Drug Delivery Rev.,48, pp. 3-26 (2001).
McMahon et al., “VEGF Receptor Signaling in Tumor Angiogenesis,”The Oncologist,5 (suppl 1): pp. 3-10 (2000).
Jinrong Fu et al., “Anti-apoptotic role . . . ,”Biochemical and Biophysical Research Comm.,349, pp. 504-512 (2006).
Pinedo et al., “Translational Research . . . ,”The Oncologist,5 (suppl 1): pp. 1-2 (2000).
Office Action of Dec. 28, 2009 in U.S. Appl. No. 11/723,893.
Office Action of Jul. 20, 2009 in U.S. Appl. No. 11/723,893.
Office Action of Jun. 24, 2009 in U.S. Appl. No. 11/665,385.
Database WPI Week 199323, Thomson Scientific, London, GB 1993-186830, XP002540626.
International Preliminary Report on Patentability dated Apr. 15, 2010, PCT/JP2008/066944.
International Preliminary Report on Patentability dated Oct. 30, 2008, PCT/JP2007/055813.
Notice of Allowance of Feb. 23, 2010 in U.S. Appl. No. 11/665,385.
Notice of Allowance of May 6, 2010 in U.S. Appl. No. 11/723,893.
Office Action of Feb. 25, 2009 in U.S. Appl. No. 11/665,385.
Office Action of Mar. 30, 2009 in U.S. Appl. No. 11/723,893.

Affiliated with

Also associated with

Rating

2,3-dihydro-iminoisoindole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2,3-dihydro-iminoisoindole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,3-dihydro-iminoisoindole derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4190840